Abbott LaboratoriesABT recently received Food and Drug Administration (“FDA”) approval for its Tendyne transcatheter mitral valve replacement (TMVR) system. The Tendyne system replaces mitral valves ...

Abbott Laboratories ABT recently received Food and Drug Administration (“FDA”) approval for its Tendyne transcatheter mitral valve replacement (TMVR) system. The Tendyne system replaces mitral valves ...

Abbott Laboratories ABT will release earnings results for the second quarter, before the opening bell on Thursday, July 17. Analysts expect the North Chicago, Illinois-based company to report ...

There’s huge movement on the mitral valve landscape this month, as Foldax is reporting reaching a regulatory milestone for the Tria Mitral Valve. The Salt Lake City, UT-based company has won approval ...

Abbott announced the US Food and Drug Administration (FDA) has approved the company's Tendyne transcatheter mitral valve replacement (TMVR) system to treat people with mitral valve disease. This ...

Abbott Laboratories ABT has recently received Food and Drug Administration (“FDA”) approval for its Tendyne transcatheter mitral valve replacement (“TMVR”) system. The Tendyne system replaces mitral ...

Abbott said Tuesday it received Food and Drug Administration approval for the Tendyne transcatheter mitral valve replacement system to treat calcium buildup in the ring that supports the heart valve.

Abbott Laboratories (NYSE:ABT) has received FDA approval today for its Tendyne™ transcatheter mitral valve replacement (TMVR) system, the first device of its kind approved in the US to treat mitral ...

The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular calcification (MAC) Tendyne offers a ...